The incidences of Barrett's oesophagus and oesophageal adenocarcinoma are rising. However there is no evidence on whether the incidence of gastroesophageal reflux disease is rising. This was a retrospective study investigating the incidence of gastroesophageal reflux disease at endoscopy from 1980 to 1995. The study took place in Tayside, Scotland. Using the Tayside endoscopy database, patients with new diagnoses of Barrett's oesophagus and endoscopic oesophagitis were identified. Cases and rates (per 1000 endoscopies) for oesophagitis, Barrett's oesophagus and combined group of oesophagitis þ Barrett's oesophagus were calculated for each year. There was a significant decline in the incidence of oesophagitis. There was a significant large increase in the incidence of Barrett's oesophagus and a small but significant rise in the incidence of endoscopically identified gastroesophageal reflux disease (oesophagitis þ Barrett's oesophagus). There was a significant decrease in the ratio of new cases of oesophagitis to new cases of Barrett's oesophagus. At endoscopy there has been a small increase in incidence of gastroesophageal reflux disease. There has, however, been a dramatic change in the spectrum of gastroesophageal reflux disease, with a larger proportion having Barrett's oesophagus than previously.
Introduction
The incidence of oesophageal adenocarcinoma is rising and the presence of Barrett's oesophagus is the main risk factor for oesophageal adenocarcinoma (Cameron et al., 1995; McKinney et al., 1995) . Barrett's oesophagus refers to the presence of columnar epithelium in the lower oesophagus instead of the normal squamous epithelium. A more accurate term for this premalignant condition is columnar lined oesophagus (CLO). It has previously been shown that the incidence of Barrett's oesophagus in Tayside has dramatically risen and this observation has been confirmed elsewhere (Prach et al., 1997; Watson et al., 1999) . It has been suggested that this increased incidence of Barrett's oesophagus may reflect an increased incidence of gastroesophageal reflux disease as a whole, Barrett's oesophagus being regarded as the severe end of the gastroesophageal reflux disease spectrum.
There are currently no data to suggest that the increased incidence of Barrett's oesophagus is related to increasing incidence of gastroesophageal reflux disease. Indeed, there are no data to confirm or deny that the incidence of gastroesophageal reflux disease is rising. This study sought to address these issues.
Methods
The endoscopy database for Tayside was used to identify all new cases of oesophagitis and Barrett's oesophagus from 1980 to 1995. Tayside is a region in Scotland, with a stable population of approximately 384 000. The diagnoses of oesophagitis and Barrett's oesophagus were based on the endoscopist report alone. During the period of the study in Tayside, the diagnosis of Barrett's oesophagus required at least 3 cm of columnar lined oesophagus. The diagnosis of oesophagitis required the presence of erosions in the oesophagus. Cases and rates (per 1000 endoscopies) of newly diagnosed oesophagitis, Barrett's oesophagus and combined group (oesophagitis þ Barrett's oesophagus) were stratified by the year of diagnosis. The combined group of oesophagitis and Barrett's oesophagus measured the total amount of endoscopically identifiable gastroesophageal reflux disease. Statistical analysis used chi-square test for trend. 
Discussion
This study relied on the endoscopist report alone of Barrett's oesophagus. At present the diagnosis requires endoscopic appearances suggestive of Barrett's oesophagus and the presence of intestinal metaplasia. However, the proposals from the British Society of Gastroenterology for the management of Barrett's oesophagus do not require the presence of intestinal metaplasia for its diagnosis. For the majority of the study period, it was generally accepted that the diagnosis of Barrett's oesophagus required at least 3 cm of columnar lined oesophagus. This was the criterion used in Tayside for the period under study. The increase in cases of Barrett's oesophagus could not be accounted for by the recognition of short segment Barrett's oesophagus.
These results suggest that there has been a small increase in the incidence of gastroesophageal reflux disease as diagnosed by endoscopy. The rate of new diagnoses of oesophagitis actually fell, whereas the rate of new diagnoses of Barrett's oesophagus rose. The small increase in incidence of gastroesophageal reflux disease may be an underestimate. During the period under study, acid suppression therapy was increasingly used. Some patients with gastroesopha- 
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geal reflux disease may have been taking acid suppressants at the time of endoscopy. This could have led to some of them having a normal endoscopy, because the acid suppression therapy had healed their oesophagitis. However we cannot infer from this small rise in incidence of gastroesophageal reflux disease at endoscopy that the overall incidence in the community has increased. Referral patterns may have changed as the incidence of peptic ulcer disease has declined and the perception of the importance of gastroesophageal reflux disease has increased, especially with the availability of effective treatments. Bardhan et al. (2000) have suggested that the incidence of gastroesophageal reflux disease is rising rapidly, but they have not made any allowance for the above factors.
The spectrum of gastroesophageal reflux disease has changed dramatically over the study period. A greater proportion of those with endoscopically diagnosed reflux disease have Barrett's oesophagus. The increasing incidence of Barrett's oesophagus, as previously suggested, may be due to increasing awareness of the condition. We cannot control for this. Indeed the sharp rise in new diagnoses of Barrett's oesophagus between 1988 and 1990 suggests that there may be an element of increasing awareness of the condition. However, the increasing incidence of oesophageal adenocarcinoma would suggest that the increasing incidence of Barrett's oesophagus is actually occurring and not just an artefact of increasing awareness of this condition.
The factors responsible for this change in spectrum of gastroesophageal reflux disease are not clear. Changing lifestyle patterns, changing incidence of Helicobacter pylori infection and treatment of reflux symptoms with acid suppression may be explanatory factors. The identification of the factors responsible for the change in spectrum of reflux disease may allow interventions to be made to reduce the incidence of Barrett's oesophagus and consequently the incidence of oesophageal adenocarcinoma.
